Oscillatory positive expiratory pressure (OPEP) devices have been used as a supplement to traditional chest physiotherapy (CPT) to aid in the clearing of respiratory secretions in people who can’t cough, especially those with chronic conditions. In chronic airway disorders such as cystic fibrosis, bronchiectasis, bronchitis, bronchial asthma, and primary ciliary dyskinesia syndrome, the usage of OPEP devices is still limited. In chronic obstructive pulmonary disease (COPD), oscillating positive expiratory pressure (OPEP) devices are said to help with sputum clearance.
Johnson and Johnson Services, Inc, Stryker Corporation –are Notable Market Players in Global Oscillating Positive Expiratory Pressure (OPEP)Devices Market
The growth of the market is attributed to growing prevalence of chronic obstructive pulmonary disease (COPD) and asthma and rising technological advancements drive the market growth. However, the low awareness and limited access to OPEP devices hampers the market growth.
Market leaders operating in the market have undertaken various organic and inorganic growth strategies. The global Oscillating Positive Expiratory Pressure (OPEP)devices market majorly consists of players like Allergan Plc., PARI GmbH, Smiths Medical, AirPhysio, D•R BURTON HEALTHCARE, Medica Holdings, LLC, CEGLA Medizintechnik GmbH & Co. KG, Able Healthcare, Trudell Medical International, and Mercury Medica among others.
Several in organic approaches, such as product launches, and expansion in the global oscillating positive expiratory pressure (OPEP) devices market, have resulted in the growth of the market. Likewise, inorganic strategies such as mergers & acquisitions, and collaboration have helped the company to strengthen its revenue, which allows the company to hold a strong position in the market.
Below is the list of the growth strategies done by the players operating in the global oscillating positive expiratory pressure (OPEP) devices market:
| Year | News |
| Jan-2022 | Patients in the U.S. with chronic obstructive pulmonary disease (COPD) or other respiratory disorders now can have their own AirPhysio device from Life Wellness Healthcare delivered to their homes, thanks to an upgrade the company made to its online store. |
| May-2021 | Monaghan Medical Corporation (Monaghan), a Trudell Medical Corporation subsidiary, and Captis have signed a three-year agreement, forming a partnership between two industry leaders. The exclusive source agreement recognises the significance of Monaghan’s patient outcome evidence and gold standard medical equipment, as well as Captis’ aim to improve process efficiency and spend money wisely on healthcare |
| Mar-2020 | D•R Burton Healthcare Products LLC launched the OxyPAP Positive Airway Pressure (PAP) device, delivering oxygen flow with unique hygiene protection for patients needing lung expansion therapy. The OxyPAP is unique in that it can be used in conjunction with other D•R Burton products to provide oxygen flow to patients who require secretion clearance during Oscillating Positive Expiratory Pressure (OPEP) therapy. |
| Feb-2020 | Smiths Medical, a pioneering global medical device manufacturer, announced the launched an Oscillatory Positive Expiratory Pressure (OPEP) therapy educational programme on the Doctors.net.uk network.ss |
